Evaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza

Influenza and other Respiratory Viruses

Volumn 7, Issue 2, 2013, Pages 160-167

  Coleman, Laura A ^a   Waring, Stephen C ^b   Irving, Stephanie A ^a   Vandermause, Mary ^a   Shay, David K ^c   Belongia, Edward A ^a  

^a MARSHFIELD CLINIC   (United States)

^b ESSENTIA INSTITUTE OF RURAL HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Body mass index; Influenza; Obesity

Indexed keywords

ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGE; ARTICLE; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEASON; THROAT CULTURE;

ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NASOPHARYNX; OBESITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; YOUNG ADULT;

EID: 84873730243     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00377.x     Document Type: Article

References (33)

1. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006; 39:137-141.
2. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254:3187-3189.
3. Kim YH, Kim JK, Kim DJ et al. Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J Infect Dis 2012; 205:244-251.
4. O'Rourke RW, Kay T, Scholz MH et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg 2005; 15:1463-1468.
5. O'Rourke RW, Kay T, Lyle EA et al. Alterations in peripheral blood lymphocyte cytokine expression in obesity. Clin Exper Immunol 2006; 146:39-46.
6. Nieman DC, Henson DA, Nehlsen-Cannarella SL et al. Influence of obesity on immune function. J Am Diet Assoc 1999; 99:294-299.
7. Sheridan PA, Paich HA, Handy J et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obesity 2011; 16. doi:10.1038/ijo.2011.208.
8. Dinelli MI, Moraes-Pinto MI. Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder. Rev Inst Med Trop Sao Paulo 2008; 50:129-130.
9. Ahmed T, Das SK, Golden JK, Saltzman E, Roberts SB, Meydani SN. Calorie restriction enhances T-cell-mediated immune response in adult overweight men and women. J Gerontol A Biol Sci Med Sci 2009; 64:1107-1113.
10. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007; 137:1236-1243.
11. Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2008; 126:268-279.
12. O'Brien KB, Vogel P, Duan S et al. Impaired wound healing predisposes obese mice to severe influenza virus infection. J Infect Dis 2012; 205:252-261.
13. Napolitano LM, Park PK, Sihler KC et al. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1-4.
14. Morgan OW, Bramley A, Fowlkes A et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010; 5:e9694.
15. Louie JK, Acosta M, Samuel MC et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011; 52:301-312.
16. Van Kerhove MD, Vandemaele KAH, Shinde V et al. Risk factors for severe outcomes following 2009 Influenza A (H1N1) Infection: a global pooled analysis. PLoS Med 2011; 8:e1001053.
17. Orenstein EW, De Serres G, Haber MJ et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-631.
18. Bertakis KD, Azari R. Obesity and the use of health care services. Obes Res 2005; 13:372-379.
19. Belongia EA, Kieke BA, Donahue JG et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-167.
20. Belongia E, Kieke B, Coleman L et al. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine - Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep 2008; 57:393-398.
21. Belongia EA, Irving SA, Waring SC et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010; 304:1091-1098.
22. Liao RS, Tomalty LL, Majury A, Zoutman DE. Comparison of viral isolation and multiplex real-time reverse transcription-PCR for confirmation of respiratory syncytial virus and influenza virus detection by antigen immunoassays. J Clin Microbiol 2009; 47:527-532.
23. World Health Organization. CDC Protocol of Realtime RTPCR for Swine Influenza A (H1N1). http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf2009. Accessed June 29, 2011.
24. Coleman LA, Kieke B, Irving S et al. Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). Vaccine 2011; 29:387-390.
25. Arterburn DE, Alexander GL, Calvi J et al. Body mass index measurement and obesity prevalence in ten U.S. health plans. Clin Med Res 2010; 8:126-130.
26. NHLBI Working Group. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Washington, D.C.: National Institutes of Health, 2000.
27. Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009; 27:6546-6549.
28. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME. Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Pediatr 2010; 49:777-781.
29. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000; 160:3082-3088.
30. Gilca R, De Serres G, Boulianne N et al. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respir Viruses 2011; 5:247-255.
31. Couch RB, Atmar RL, Franco LM et al. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults. Clin Infect Dis 2012; 54:311-317.
32. Easterbrook JD, Dunfee RL, Schwartzman LM et al. Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respir Viruses 2011; 5:418-425.
33. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the 'beef'? Int J Obesity 2007; 31:1552-1553.